MarkRGilbertMD

Neurology • Houston, TX

Neurophysiology, Neurooncology

Associate Professor of Neurology, University Tex Houston

Join to view full profile

Are you Dr. Gilbert?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 86 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Summary

Dr. Mark Gilbert, MD is a board certified neurologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and California. He is affiliated with University of Texas M.D. Anderson Cancer Center and is an Associate Professor of Neurology at University Tex Houston.

Education & Training

Johns Hopkins UniversityResidency, Neurology, 1984 - 1987
Johns Hopkins UniversityResidency, Internal Medicine, 1982 - 1984
Johns Hopkins University School of MedicineClass of 1982

Certifications & Licensure

TX State Medical License 2001 - 2025
FL State Medical License 2005 - 2016
NY State Medical License 2002 - 2016
CA State Medical License 2003 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology

Clinical Trials

Chemotherapy and Whole-Brain Radiation Therapy in Treating Patients With Primary Central Nervous System Non- Hodgkin's Lymphoma Start of enrollment: 1995 Jul 01
Completed
Phase 2
Lonafarnib and Temozolomide in Treating Patients With Glioblastoma Multiforme That Is Recurrent or Did Not Respond to Previous Treatment With Temozolomide Start of enrollment: 2004 Dec 21
Active, not recruiting
Phase 1
Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma Start of enrollment: 2006 Jan 01
Completed
Phase 3
Brain Tumor Patient-Caregiver Congruence, MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) Start of enrollment: 2008 May 01
Completed
Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma Start of enrollment: 2009 Jan 01
Completed
Phase 2
Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients Start of enrollment: 2009 Jan 01
Completed
Carboplatin and Bevacizumab for Recurrent Ependymoma Start of enrollment: 2011 Apr 27
Completed
Phase 2
Lacosamide in Preventing Seizures in Participants With Malignant Glioma Start of enrollment: 2012 Jul 25
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

2653 citations
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen, David R. Macdonald, David A. Reardon, Timothy F. Cloughesy, A. Gregory Sorensen
Journal of Clinical Oncology. 2010-04-10
63 citations
Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007.
E. Susan Amirian, Terri S. Armstrong, Kenneth Aldape, Mark R. Gilbert, Michael E. Scheurer
Neuroepidemiology. 2012-07-28
117 citations
Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma.
Aaron P. Brown, Christian L. Barney, David R. Grosshans, Mary Frances McAleer, John de Groot
International Journal of Radiation Oncology, Biology, Physics. 2013-06-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member